European Biotech Acquisition Corp.
EBACNASDAQFinancial Services
$11.19
$-0.52(-4.44%)
Market Cap$183500312
P/E Ratio—
52W High$14.1
52W Low$9.282
European Biotech Acquisition Corp. (EBAC) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · EBAC · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2022-12 | 2021-12 |
|---|---|---|
| Revenue | ||
| Revenue | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B |
| Gross Profit | $0.00B | $0.00B |
| Gross Margin %(computed) | — | — |
| Operating Expenses | ||
| R&D Expenses | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B |
| Total Operating Expenses | $0.00B | $0.00B |
| Operating Income | ($0.00B) | ($0.00B) |
| Operating Margin %(computed) | — | — |
| Interest Income | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B |
| Income Before Tax | $0.00B | $0.00B |
| Income Tax Expense | ($0.00B) | $0.00B |
| Net Income | $0.00B | $0.00B |
| Net Margin %(computed) | — | — |
| Per Share & EBITDA | ||
| EPS (Basic) | $0.27 | $0.43 |
| Wtd Avg Shares | 0.01B | 0.00B |
| EBITDA | ($0.00B) | ($0.00B) |
| EBITDA Margin %(computed) | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · B
Explore more European Biotech Acquisition Corp. data
About European Biotech Acquisition Corp. (EBAC) Income Statement
European Biotech Acquisition Corp. (EBAC) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2022, EBAC reported revenue of $0.00B, gross profit of $0.00B (gross margin —), and net income of $0.00B — a net profit margin of —.
Frequently asked questions
EBAC · 4 questionsEuropean Biotech Acquisition Corp. (EBAC) reported revenue of $0.00B for 2022, down —% year-over-year.
EBAC revenueEBAC salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09